HCV Advocate Newsletter: 2015
This site includes links to files you can view online or print. To download and print information, you will need the latest version of Adobe Acrobat Reader. Download it free. 
 |
 |
- The Liver Conference 2015 – Part 2
- Disability Insurance – A Survival Guide
- HCV Advocate Monthly Pipeline Update
- What’s New!
- Additionally, we are recommending HEP: www.hepmag.com –an excellent website that educates and supports the viral hepatitis community.
- Feds to Medicaid: Stop HCV Treatment Restrictions
- Gilead Applies for FDA Approval
- Social Security and Medicare Changes for 2016
- HCV Drugs
- HCV SnapShots
- The Five: Pan-Genotypic Drugs
- What’s New
- Hepatitis C Workshop Schedule
Please note:
During the transition from our old website to our new website, the daily log of the people who had signed up was deleted. If you would like to continue to receive the daily digest, you will need to sign up again; you can do so by clicking on any (or all) of the links below.
Subscribe to HCV Advocate News & Pipeline Blog by Email
Subscribe to HBV Advocate Blog by Email
Subscribe to Hepatitis and Tattoos by Email
- Snapshots
- Harvoni Treatment Choices and Outcomes
- HealthWise: Hepatitis C: Letting Go of Fear
- Sam’s Story
- Hepatitis C Workshop Schedule
- Dr. David Mazoff Retires
- Disability & Benefits: Open Enrollment Final
- The Five: Clinical Trials
- Snapshots
- What’s New! Tattoos fact sheets now on this site
- THE FIVE: Cirrhosis
- SNAPSHOTS
- DISABILITY & BENEFITS: Emotional Issues When Leaving Work on a Disability
- HCV DRUG PIPELINE—Quarterly Update
- WHAT’S NEW! Hepatitis C Training Workshop Schedule
- HEPATITIS C in CHILDREN
- HEALTHWISE: Big Questions about Hepatitis C
- SNAPSHOTS
- CONSUMER REPORTS BEST BUY DRUGS BOOKLET
- WHAT’S NEW!
- HCV Drugs: AbbVie, BMS, Merck
- DISABILITY & BENEFITS: Balance Billing by Out-of-Network Providers
- THE FIVE: HCV Myth Busters
- SNAPSHOTS
- WHAT’S NEW!
- A Brief Overview: Outbreaks of Acute HCV Infections in the U. S.
- HEALTHWISE: Hepatitis C and Nonalcoholic Fatty Liver Disease
- SNAPSHOTS
- FDA SAFETY ALERT
- PATIENTS FIRST: HCV and Depression
- WHAT’S NEW!
- Hepatitis C: The Problem with Numbers
- THE FIVE: The Next HCV Drugs
- DISABILITY & BENEFITS: Medicare at Age 65
- SNAPSHOTS
- WHAT’S NEW!
- A Brief Overview of Liver Toxic Herbs
- HEALTHWISE: Hepatitis C and Pain – Part 2
- SNAPSHOTS
- PATIENTS FIRST: Antacid, Pregnancy Categories and Herbs
- A NEW POWERFUL HCV HEALTH TOOL
- WHAT’S NEW!
- THE FIVE: HCV Genotypes
- GENOTYPE 3: An Unmet Need for Some
- DISABILITY & BENEFITS: Who Is Disabled?
- HCV Drugs
- GENOTYPE 5
- WHAT’S NEW!
- EASL 2015: Part 2
- HEALTHWISE: Hepatitis C and Pain – Part 1
- SNAPSHOTS
- NEW VIRAL HEPATITIS NUMBERS FROM THE CDC
- PATIENT ASSISTANCE
- WHAT’S NEW!
- EASL 2015: Snapshots
- DISABILITY & BENEFITS: Planning for Disability
- THE FIVE: May Is Hepatitis Awareness Month
- HEALTHWISE: Hepatitis C Awareness: A Little Effort Makes a Big Difference
- PATIENTS FIRST: Overview – Preparing for Treatment: Part 2
- WHAT’S NEW!
- HCV DRUGS
- SNAPSHOTS
- SNAPSHOTS
- THE FIVE: Coffee
- WHAT’S NEW!
- UPDATES: Herbal Supplement Crackdown—GNC Reforms
- DISABILITY & BENEFITS: SSI and SSDI: Social Security’s TWO Disability Programs
- SPANISH HCSP FACT SHEETS: Updated
- Hepatitis on the Hill
- HEALTHWISE: Hepatitis C: Giving a Liver, Getting a Liver
- HCV DRUGS
- SNAPSHOTS
- PATIENTS FIRST: Overview – Preparing for Treatment: Part 1
- HCV in Japan
- SNAPSHOTS
- THE FIVE: Diabetes
- WHAT’S NEW!
- DISABILITY & BENEFITS: COBRA Continuation Coverage and Obamacare
- HCV Drugs
- HEALTHWISE: Children with Hepatitis C
- PATIENTS FIRST: Price Wars, Treatment Outcomes, Longevity
- SNAPSHOTS
- The Global Spread of Genotype 1
- HERBAL SUPPLEMENT CRACKDOWN
- THE FIVE: Sleep and Insomnia
- WHAT’S NEW!
- DISABILITY & BENEFITS: Reallocation; ACOs; ABLE Accounts (Update on Federal Government Actions)
- SNAPSHOTS
- Hepatitis C Treatment and Pregnancy
- HCV DRUGS: Triple Drug Regimens, Exclusivity Deals & Merck Update
- THE FIVE: Fatigue
- PREDICTORS OF TREATMENT RESPONSE
- SNAPSHOTS
- Genotype 2: Prevalence, Cure and Viral Diaspora
- HCV DRUGS: AASLD 2014: Ledipasvir and Sofosbuvir in African Americans
- WHAT’S NEW! Updated: Side Effect Fact Sheets and HIV/HCV Coinfection Fact Sheets
- SNAPSHOTS
- THE FIVE: The Flu
- DISABILITY & BENEFITS: Family & Medical Leave Laws
- HCV Advocate’s Top News of 2014
- HCV DRUGS: AbbVie’s VIEKIRA PAK Approval & AASLD 2014
- PATIENTS FIRST: HCV and Depression
- HEALTHWISE: Denied Hepatitis C Treatment? Here is How to Fight Back
- SNAPSHOTS
- WHAT’S NEW!
Follow Us
